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Abstract
Protective Th1 responses to Salmonella enterica do not develop in the absence of B cells. Using
chimeric mice, we dissect the early (innate) and late (cognate) contributions of B cells to Th
programming. B cell intrinsic MyD88 signaling is required for primary effector Th1 development,
while antigen-specific BCR-mediated antigen presentation is necessary for the development of
memory Th1 populations. Programming of the primary T cell response is BCR/B cell MHC II-
independent but requires MyD88-dependent secretion of cytokines by B cells. Chimeras in which
B cells lack IFN-γ or IL-6 genes make impaired Th1 or Th17 responses to Salmonella.
INTRODUCTION
The main function of B cells is to make antibodies that provide protection against potential
pathogens. Sometimes, due to a failure of tolerance, B cells also make antibodies that bind
self-antigens and so cause autoimmune disease. For this reason B cell depletion therapy is
increasingly used in the rheumatology clinic (1). In some patients the treatment is effective
despite unchanged autoantibody titers (2), highlighting antibody-independent functions of B
cells, including antigen presentation and cytokine secretion (3-5).
B cells present antigen very effectively only when they take up antigen via their B cell
receptor (BCR) (6), however, their exact role as antigen presenting cells (APC) in vivo
remains unclear (7-12). B cells begin to contribute as APC during the primary response (8,
11, 13), however, their major impact is thought to be in the re-activation of CD4 memory T
cells (14-18). Cytokine production by B cells extends their sphere of influence to the
development of lymphoid tissue microenvironments (19) and regulation of T cell responses
(20-22). For instance, the secretion of IL-10 by B cells modulates T cell function (23, 24) to
bring about resolution of inflammation in autoimmune disease models (25-27). Regulatory
B cell activity has also been seen in infection models protecting against acute Th1 (24, 28)
and chronic Th2 (29-31) inflammation.
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In influencing T cell responses, B cells usually show a propensity to drive Th2 responses
(32-35). Lund and colleagues (4) demonstrated that B cells can be polarized in their cytokine
production in the same way as CD4 T cells, to become Be1 (36) and Be2 cells (37). More
recently, cytokine production by B cells was shown to be necessary for the development of
protective antibody-mediated Th2 immunity to H. polygyrus infection (38). As the Be2 cells
were required to express IL-4R (38), this seemed to involve cross-talk between T cells and B
cells rather than any exogenous pathogen-associated signal. Like other APC, B cells express
a broad range of toll-like receptors (TLR) that upon ligation stimulate the secretion of
cytokines (39). The direct stimulation by TLR ligands of cytokine production by B cells
offers a means to influence at an early stage the differentiation of Th subsets.
To address this issue and to investigate differential roles of TCR and BCR in the
programming potential of B cells we chose an infection model in which both TLRs and BCR
would be stimulated as the disease progressed and one that generates a strong Th1 response.
Salmonella enterica serovar Typhimurium is a bacterium that resides within the phagosomal
compartment of macrophages (40). The infection has a transient extracellular phase, during
systemic dissemination (41). To combat the infection, macrophages must be activated by
inflammatory cytokines (42, 43). Thus, Th1 CD4 responses are crucial for the clearance of
the bacteria and for protective immunity upon re-infection (44, 45). B cells have two roles,
first as producers of antibodies (46, 47) and second, an antibody-independent role (48, 49).
Thus, B cell deficient mice can clear infection, however, the Th1 response they develop is
transient and they are not protected from re-infection with a virulent strain (50).
In this study, we find that B cells contribute to the early phase of T cell programming via a
MyD88-dependent mechanism and are required in a BCR-dependent process for the
development of the memory T cell response. Thus, TLR activation of B cells optimises the
generation of the primary Th1 response, a process that does not require antigen presentation
but relies on B cell cytokine secretion. For the development of Th1 memory cells and hence
protective immunity to Salmonella, BCR recognition and B cell antigen presentation are an
absolute requirement.
MATERIALS AND METHODS
Mice and generation of bone marrow chimeras
C57BL/6, μMT, MyD88−/−, BALB/c, JHD and MD4 mice were aged 6-10 weeks old at the
start of experimental regimes. Mixed bone marrow chimeric mice were generated as
described previously (51). Briefly, host B cell-deficient mice (μMT) were lightly irradiated
with 8Gy of gamma-radiation. Mice were then reconstituted with 2×106 mixed-inoculum
bone marrow cells (80% B cell-deficient marrow (μMT) and 20% knock-out or WT
marrow). To control for a possible deficiency of 20% in other hematopoietic cells we made
chimeras in which 20% of all the hematopoietic lineages are derived from gene-deficient
bone marrow (by transferring 80% wild-type bone marrow + 20% gene-deficient bone
marrow into irradiated recipients). Results from these chimeras and further validation of the
chimera model is provided in Supplemental Fig. 1). MyD88−/− mice (52) and TRIF−/− (53)
were provided by S. Akira (Hyogo College of Medicine, Japan). BCR transgenic MD4 strain
(54). JHD (BALB/c B cell-deficient (55) and μMT (C57/BL6 B cell-deficient (56) IFNγ−/−
(57), IL-6−/− (58), I-Aβ−/− (59) mice have been bred in-house long-term and have been
backcrossed to C57Bl/6 or BALB/c (MD4 and JhD) in excess of 10 generations.
Experiments were covered by a Project Licence granted by the UK Home. This licence was
approved locally by the University of Edinburgh Ethical Review Committee.
Barr et al. Page 2
J Immunol. Author manuscript; available in PMC 2013 August 17.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Salmonella enterica serovar Typhimurium infection
The aroA attenuated strain of S. enterica serovar Typhimurium, SL3261, was used for all
infections (60). Bacteria were grown as stationary-phase overnight cultures in Luria-Bertani
(LB) broth. Animals were injected intravenously (i.v.) with 1×106 CFU.
Preparation of bacterial antigens
Bacterial antigen (C5SENaOH) was prepared as described previously (61). Briefly,
overnight stationary-phase cultures of the C5 strain were washed twice in PBS containing
5mM EDTA. The resulting suspension was sonicated on ice and cellular debris removed by
centrifugation at 13,000g. The supernatant was alkali-treated with 5M NaOH for 3 h at 37°C
and then neutralised with HCl. The NaOH-treated antigen was then 0.22um sterile filtered
and stored at −80°C. Protein content was calculated using a standard Bradford assay. Heat-
killed bacteria (HKB) were prepared by pelleting cells from snap-frozen stock vials of
SL3261, re-suspending in complete Iscove’s modied Dulbecco’s media (IMDM) then
heating to 80°C for 30 mins.
Preparation and sorting of CD4+ve and CD19+ve lymphocytes
CD4+ve and CD19+ve lymphocytes for use in all in vitro re-stimulation assays were isolated
from mice using standard magnetic sorting techniques. Following manual disruption and
lysis of red blood cells, splenocytes were positively sorted using anti-CD19 or anti-CD4
microbeads and LS columns according to manufacturer’s instructions (Miltenyi-Biotech).
CD4 T cells and B cells were greater than 98% pure following 2-column passes.
In vitro re-stimulation assays
Highly purified B cells from SL3261 infected mice were cultured (2×106 cells/ml) for 5
days with stimuli including; HKB SL3261, Salmonella LPS (1μg/ml - InVivogen), PMA
and ionomycin (10ng/ml and 1μg/ml – Sigma). Supernatants were harvested at day 5. T cell
re-stimulation assays were set up by co-culturing highly purified CD4 T cells with irradiated
(30Gy) wild-type, naïve splenocytes at a 1:1 ratio (2×106 cells/ml). Supernatants were
harvested at 24 hours for IL-2 and 72 hours for IFNγ, IL-10, and IL-17 detection.
Cytokine ELISA
Paired antibody sets for IFNγ, IL-2, IL-6, IL-10 and IL-17 (BD Bioscience) were used for
capture and detection in ELISA assays Cytokine concentrations were determined by
extrapolation from a standard curve. Minimum levels of detection were; IL-2 = 0.2ng/ml,
IL-6 = 0.3ng/ml, IL-10 = 0.1ng/ml, IL-17 = 0.1ng/ml, and IFNγ = 0.4ng/ml.
RESULTS
BCR and TLR signals are necessary for cytokine secretion by B cells in Salmonella
infected mice
We wished to investigate the relative importance of BCR and TLR stimulation in the B cell
cytokine response. To address the antigen specificity of the bacteria-elicited cytokine
response, we infected anti-HEL BCR (MD4) transgenic mice with S. enterica and then re-
stimulated purified B cells from these mice in vitro with HKB. We found that cytokine
secretion was substantially impaired in B cells unable to respond to the bacteria through
their BCR (Figure 1A). Some IL-6 and IL-10 was still secreted by the MD4 B cells,
indicating only a partial dependence on BCR signals. However, B cells from S. enterica-
infected MD4 mice made no detectable IFNγ, indicating a total dependence on BCR
stimulation for IFNγ secretion (Figure 1A). To confirm that B cells from MD4 mice could
not respond via any endogenous BCR re-arrangements (receptor editing) we measured anti-
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Salmonella antibody responses in these mice. Antibody was undetectable up to 51 days post-
infection (Fig. 1B). Experiments have been repeated with MD4 mice crossed onto a JhD
background (endogenous BCR re-arrangements not possible), with identical results.
To address the TLR-dependency of B cell cytokine production during S enterica infection
we used MyD88-deficient mice. Thus, MyD88-deficient mice were infected with S enterica
and splenic B cells taken for in vitro re-stimulation with HKB at 7 days. IL-6, IL-10 and
IFNγ secretion was negligible, illustrating total dependence upon TLR stimulation of B
cells for secretion of these cytokines by B cells (Fig. 1A). Normal BCR reactivity in
MyD88−/− mice was confirmed by measuring antibody responses during infection; these
mice showed titres of anti-Salmonella total immunoglobulins roughly equivalent to wild-
type controls (Fig. 1B). It was not possible to assign cytokine production to particular B cell
subsets, as during Salmonella infection classical subset distinctions cannot be made (see
Supplemental Fig. 2).
MyD88 signals to B cells enhance primary development of CD4 Th1 and IL-10 responses,
but are dispensable for memory development
To study the role of MyD88 signalling in B cells as APC in the development of CD4 Th1
responses during S enterica infection, we constructed bone marrow chimeric mice in which
the B cells lacked MyD88. Thus, transfer of bone marrow cell inocula from MyD88−/− mice
and from B cell-deficient (μMT) mice in a 20:80 ratio into irradiated μMT recipients meant
that after reconstitution the B cell compartment was wholly MyD88-deficient while the
other hematopoietic populations were mainly wild-type with respect to MyD88. Further
validation of this chimera model is provided in Supplemental Fig. 1. CD4 T cells were
isolated from the spleens of MyD88B−/− and WT chimeras at the peak of primary infection
(day 7) and also after mice had cleared the infection (8 weeks). These T cells were re-
stimulated in vitro with an S. enterica antigen preparation. The B cells in these chimeras
showed equivalent expression of activation markers (Supplemental Fig. 2B). Figure 2A
shows IL-2, IFNγ and IL-10 production by CD4+ T cells at the peak of primary infection
(day 7). IFNγ and IL-10 production are significantly impaired in the primary responses,
with T cell derived IL-10 being particularly dependent upon B cell MyD88 expression (both
P<0.0001). IL-2 production from T cells was below the limit of detection during the primary
response in MyD88B−/− and WT chimeric mice. Thus, MyD88-dependent (TLR) stimulation
of B cells in vivo is necessary for optimal Th1 differentiation of CD4+ T cells and also for
the generation of IL-10 producing T cells during S. enterica infection. MyD88 also acts as a
signaling adapter for IL-1 and IL-18, however, we feel that the effect on Th1 response
development shown here is TLR-mediated, as we see a similar impairment of the IFN-γ
response in TRIF−/− knockout mice (Supplemental Fig. 3).
At week 8 post-infection when bacteria had been cleared we harvested CD4+ T cells from
spleens of infected chimeras to test the memory response. This revealed robust and
equivalent cytokine secretion in both groups of chimeras. Thus, the memory IL-2, IFNγ and
IL-10 responses were similar in MyD88B−/− and WT chimeric mice. Despite the significant
reduction in early cytokine production the development of Th1 and IL-10-producing
memory T cells is not impaired. Indeed, the late/memory Th1 cell development was
sufficiently strong to resolve the infection. Bacterial burdens in the spleen at day 7 were
similar in WT, μMT and MyD88B−/− mice. MyD88−/− mice showed increased bacterial
burden at day 7, and took longer to resolve the infection, however, all types of mice clear
bacteria at a roughly similar rate (Figure 2B).
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Development of memory but not primary CD4 Th1 and IL-10-producing T cells is
dependent on antigen-specific BCR signals to B cells
MD4 transgenic mice expressing a HEL-specific BCR were used to investigate the
requirement for BCR signals to B cells in their capacity to influence primary and memory T
cell responses during S. enterica infection. CD4+ T cells were isolated from MD4 spleens at
the peak of primary infection (day 7) and re-stimulated in vitro with S. enterica antigen.
Figure 3A shows IL-2, IFNγ and IL-10 secretion by T cells from MD4 mice. At day 7, T
cells from MD4 mice showed largely normal cytokine production, with a small but
significant reduction in IFNγ (P<0.05). IL-10 secretion by T cells from MD4 mice was
equivalent to those from WT mice. Antigen specific IL-2 secretion by T cells isolated from
S. enterica-infected mice was below the limit of detection in both WT and MD4 mice.
A second cohort of animals was left to clear the infection, in order to quantify the
development of cytokine-secreting memory T cells. T cells from week 7 post-infection were
re-stimulated as previously. Figure 3A shows that at week 7 there is no antigen-specific Th1
response from these T cells (no detectable IL-2 or IFNγ; P<0.001) and it is clear that
generation of memory Th1 cells is seriously impaired in mice which cannot respond through
the BCR. Interestingly, IL-10 secretion was still apparent in T cells isolated from MD4 mice
7 weeks post immunisation, though was partially impaired (P<0.05). Thus, stimulation of B
cells through the BCR is necessary for generation of Th1 memory in Salmonella infection.
As MD4 mice clear bacteria less efficiently (Figure 3B) than wild type mice we also carried
out experiments in which the mice were treated with antibiotic from the peak of infection for
10 days. Supplemental Fig. 4 shows that similar levels of antibiotic-mediated clearance of
bacteria in MD4 and wild-type mice gave exactly the same result: the Th1 memory response
failed to develop in MD4 mice. The frequency of activated (CD44+) cells within the CD4 T
cell population are similar in MD4, uMT and WT mice, indicating there is no failure of
activation or survival (Supplemental Figure 5).
Memory T cell responses require antigen presentation by B cells whereas priming does
not
Our demonstration that primary T cell responses were influenced by B cells in an antigen
non-specific manner while memory T cell responses were dependent upon BCR suggests
antigen presentation by B cells is dispensable at early stages but crucial later on. To
investigate this further we generated mixed bone marrow chimeras in which B cells could
not present antigen via MHC class II (MHC-IIB−/−). Primary T cell responses to Salmonella
in these mice, as in BCR-irrelevant mice, were found to be largely normal (Figure 4) and
were sufficient to allow bacterial clearance. In contrast, at week 8 post-infection memory
Th1 responses (IL-2 and IFNγ secretion) were both highly dependent upon B cell
presentation (Fig 4). The same is not true of the memory IL-10 response, which is
unaffected in MHC-IIB−/− chimeras. To test if this failure of Th1 memory development
influenced the protection, we challenged the mice, 12 weeks later, with a virulent
Salmonella strain and found that they survived less well than controls (Supplemental Fig. 6).
Effect of B cell cytokine deficiency on the development of T cell responses
To see if there was a direct effect of B cell-derived cytokines on the polarization of T cell
responses we constructed bone marrow chimeras in which the B cell compartment was
deficient in IL-6 or IFNγ. In IL-6 B−/− chimeras we noted no effect on CD4 T cell derived
IL-2, IL-10 (not shown) or IFNγ responses (Figure 5A), but did note a significant decrease
in the production of IL-17 during Salmonella infection (Figure 5A),. In IFNγB−/− chimeras
the CD4 T cell derived IL-2 (not shown) and IL-10 (Figure 5B) responses were slightly
lower than in WT chimeras, but this was not statistically significant. The IL-17 response was
not altered. However, the CD4 T cell-derived IFNγ response to Salmonella was
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significantly impaired in the mice in which B cells could not secrete IFNγ (Figure 5B). In
summary, B cell-derived IL-6 and IFNγ supported development of the Th17 and the Th1
responses respectively. T cell cytokine response was not completely absent in the cytokine
chimera, so we conclude that B cell derived cytokines play an important but supporting role.
DISCUSSION
In this study we have identified two distinct and functionally separable phases of the B cell
contribution to T cell differentiation during a response to an ongoing Salmonella infection.
The first, early phase is dependent on B cell-intrinsic MyD88 signals, most likely as a result
of TLR ligation. This phase is almost wholly independent of BCR-mediated antigen uptake
or presentation to CD4 T cells via MHC class II on the B cells. B cell cytokine production is
largely MyD88-dependent and we propose that the early influence of B cells on the
developing CD4 T cell response is mediated by cytokines produced in response to TLR
ligation. In support of this we show that when B cells are incapable of making certain
cytokines (eg. IFNγ or IL-6), this has measurable effects on the development of polarized
effector T cell subsets (eg. Th1 and Th17). We do not know if the B cell-derived cytokines
act directly on activated T cells or on other cell types that influence T cell differentiation.
The second phase of B cell influence is during the development of CD4 T cell memory and
is dependent on recognition and uptake of antigens by BCR and their subsequent
presentation by MHC class II. In the absence of this cognate phase of B-T cell interaction,
the protective Th1 memory cell response fails to develop.
Evidence of the importance of B cells in the development of CD4 T cell memory has
accumulated over several years in studies using protein antigens and TCR transgenic models
(13, 17, 62). The data presented here along with other recent studies (14-16, 18, 63), shows,
during infection, the failure to develop T cell memory in the absence of antibody-
independent B cell function. We identify the expression on B cells of both an antigen-
specific BCR and MHC class II as crucial for memory T cell development, presumably to
enable antigen uptake and presentation. It is equally clear that these “cognate” molecules on
B cells are dispensable for the generation of the primary CD4 T cell response. This means
that other APC (eg. DC) are competent and sufficient to drive the primary response, strongly
suggesting that, as the response to Salmonella antigens proceeds, the participating APC
changes from the DC, initially, to B cells later on. It is not simply that B cells present
antigen upon secondary exposure, but rather perform a “follow-on” APC function as DC
presentation falls away. In support of this, the primary IFNγ response we observe in MD4
(BCR restricted) mice at day 7 is already reduced compared to control mice and this
response declines in these mice over the next 2-3 weeks. Antibody seems to play no
significant role in enhancing Ag-presentation during the primary response, as provision of
anti-Salmonella antibodies to the MD4 mice did not alter the magnitude or the longevity of
their primary response. As we did not identify individual antigen-specific memory T cells in
this study, we can say little about memory T cell survival. Our definition, of memory here is
a functional one in which we detect enhanced responsiveness to antigen recall. Thus, we do
not know if the memory we see is mediated by bona fide memory T cells or long-lived
effectors, but given that systemic CD4 T cell memory is not apparent in some mice (eg.
MD4, MHC IIB−/− chimeras), we feel this demonstrates that that functionally either or both
cell types are missing. Future studies using Salmonella that expressing a peptide epitope
detectable using MHC II tetramers will address events at a cellular level.
In previous work from this lab (13), we showed that antigen presentation by B cells affected
the T cell response as early as day 3-4 post-immunization, somewhat earlier than we indicate
here. The two studies differ in antigen delivery, here we follow the primary response to
bacterial infection, and this may lead to enhanced APC activation in comparison to protein
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immunization with adjuvant. More importantly, Crawford et al (13) used a TCR transgenic
model in which the frequency of naïve antigen-specific T cells was artificially increased:
Under these conditions it is possible that the APC capacity of endogenous DC was
insufficient to allow optimal activation of the transferred transgenic T cells and that the
“follow-on” APC function of B cells was apparent earlier. Taken together, these data
indicate that in vivo the contribution of DC is time-limited and cannot lead to optimal
memory cell development. Ahmed and colleagues (18) also saw rapid decline (within 3
weeks) of LCMV-specific CD4 T cell response in B cell-deficient mice and concluded that
B cell involvement is in the establishment and maintenance phase of CD4 T cell memory;
we would agree.
The majority of published studies that have addressed the influence of B cells on T cell
differentiation have noted their involvement in Th2 responses (32-35, 38). Here we show a
clear contribution of B cells to the development of an effective Th1 (and Th17) response to
Salmonella infection. As discussed above, for Th1 memory this relates to continued APC
function. However, in the primary response B cells are to a large extent dispensable as APC
(MD4, BCR-restricted mice and MHC IIB−/− chimeras exhibit relatively normal primary
responses). Despite this, the presence of B cells does have a measurable effect on the
development of polarised Th subsets. In MyD88B−/− chimeras the primary IFNγ and IL-10
T cell responses are significantly reduced, indicating that TLR-induced polyclonal B cell
activation during the infection elicits mediators that can act on differentiating T cells. This
conclusion is supported by our recent study of antibody responses in MyD88B−/− chimeras
in which the IFNγ-dependent IgG2c responses were most severely impaired (64). We
investigated the cytokines, known to be secreted by B cells after TLR activation (39). In
IFNγB−/− chimeras, infected with Salmonella the primary CD4 T cell IFNγ response was
lower than in control chimeras. Recent data suggests that Th1 commitment and T-bet
expression occurs in a biphasic fashion, the early phase involving TCR and IFNγ signals
and the later consolidating phase requiring IL-12 (65). Our data suggest that TLR-activated
B cells are a likely source of this early IFNγ that optimises Th1 commitment. The fact that
the T cell IFNγ response in the IFNγB−/− chimeras is only partially inhibited may be
because IL-12 has an overriding effect (65) or that there are other cellular sources of IFNγ.
It has also been shown that Salmonella can induce early innate activation of CD4 T cells that
then make IFNγ (66); whether the innate activation and IFNγ secretion by B cells
influences this T cell response is not known. In IL-6B−/− chimeras, the T cell IL-17 response
to Salmonella was reduced, which we think indicates a significant contribution by B cells of
the IL-6 required for Th17 development (67). TNFα expression by B cells has been shown
to augment Th1 effector responses in Toxoplasma gondii infection, but we have not yet
tested this in appropriate Salmonella-infected chimeras. An obvious candidate Th1
polarising cytokine is IL-12, however, mouse B cells make very little IL-12p40 (39) and
chimeras in which B cells lack IL-12, exhibit completely normal primary and memory Th1
responses to Salmonella (not shown). We show here a direct effect of B cell cytokines on the
development of effector T cell responses during infection. The worry that the use of B cell
depletion therapy in autoimmune patients might have consequences for infection is only
exacerbated by these data, as B cells, in addition to antibody production, also support the
differentiation of inflammatory, protective Th1 and Th17 responses.
The impairment of the primary T cell cytokine responses to Salmonella in MyD88B−/−
chimeras indicates the importance of an innate component of the B cell response. The
adaptive B cell response including APC function becomes absolutely crucial later (7-14
days) for sustaining the effector T cell response and enabling memory T cell formation. It
will be intriguing to discover where these two distinct phases of the B cell dependent T cell
response occur within lymphoid tissues. We conclude that a complete and rounded CD4 T
cell response is dependent on B cells.
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Figure 1. Cytokine production is dependent upon both TLR and BCR reactivity
A. CD19+ B cells from Salmonella-infected MyD88−/− and MD4 mice were isolated from
spleens at day 7 of infection and cultured for 5 days with a serial dilution of HKB as
indicated on the X-axis. In each case black symbols represent wild-type controls and open
symbols knock-out or transgenic mice. Data points represent mean values of triplicate
cultures carried out on pooled B cells from groups of 4 mice and error bars represent SEM.
Data is representative of 3 independent experiments. Naïve WT CD19+ B cells when
stimulated with HKB maximally secreted 1-4ng/ml IL-6, 1-2ng/ml IL-10 and no IFNγ.
B. Anti-Salmonella antibody titres in MD4 (left) and MyD88−/− (right) mice were
determined by ELISA on sera from 4 groups of mice bled at time points indicated (n=4-6).
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Black symbols represent wild-type controls and open symbols represent transgenic or
knock-out mice. Each data point represents an individual mouse and bars represent mean for
the group. Data is representative of 3 separate experiments.
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Figure 2. Primary Th1 responses require B cell TLR reactivity
A. CD4+ T cells from Salmonella-infected MyD88B−/− bone marrow chimeric mice were
sorted by magnetic separation at day 7 (top) and week 8 (bottom) and cultured for 3 days
with C5SENaOH at a range of concentrations as indicated on the X-axis. In each case black
symbols represent wild-type bone marrow chimeras and open symbols MyD88B−/− chimeras
(ND = not detected). Data presented is the mean of duplicate cultures on groups of 5 animals
(n=5) and is representative of 3 separate experiments. Error bars indicate SEM. Asterisks
indicate statistically significant impaired cytokine production as determined by 2-way
ANOVA (*P<0.05, **P<0.01, ***P<0.001 and NS = not significant).
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B. Bacterial load in spleens from infected mice were calculated at day 7 and week 5. Each
symbol represents CFU from an individual mice and the line represents the mean for each
group. Presented data is representative of 3 independent experiments.
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Figure 3. Development of memory Th1 responses requires BCR reactivity
CD4+ T cells from Salmonella-infected MD4 were sorted by magnetic separation at day 7
(top) and week 7 (bottom) and cultured for 3 days with C5SENaOH at a range of
concentrations as indicated on the X-axis. In each case black symbols represent BALB/c and
open symbols MD4 transgenic mice (ND = not detected). Data presented is the mean of
duplicate cultures on groups of 5 animals (n=5) and is representative of 3 separate
experiments. Error bars indicate SEM. Asterisks indicate statistically significant impaired
cytokine production as determined by 2-way ANOVA (*P<0.05, **P<0.01, ***P<0.001 and
NS = not significant). As a result of the failure to clear bacteria, memory T cell responses in
MD4 mice were tested at week 7 and not week 12.
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B. Bacterial load in spleens from infected mice were calculated at day 7 and week 7. Each
symbol represents CFU from an individual mice and the line represents the mean for each
group. Presented data is representative of 3 independent experiments.
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Figure 4. Antigen presentation by B is dispensable for the primary T cell response but is
necessary for the memory T cell response
CD4+ T cells from Salmonella-infected MHC-IIB−/− chimeras were sorted by magnetic
separation at day 7 (top) and week 8 (bottom) and cultured for 3 days with C5SENaOH at a
range of concentrations as indicated on the X-axis. In each case black symbols represent WT
chimeras and open symbols MHC-IIB−/− chimeras (ND = not detected). Data presented is
the mean of duplicate cultures on groups of 5 animals (n=5) and is representative of 4
separate experiments. Error bars indicate SEM. Asterisks indicate statistically significant
impaired cytokine production as determined by 2-way ANOVA (*P<0.05, **P<0.01,
***P<0.001 and NS = not significant).
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Figure 5. Cytokine production by B cells influences the primary effector T cell response
A. IL-17 and IFNγ responses of CD4+ T cells from spleens of Salmonella-infected IL-6B−/−
chimeras, re-stimulated in vitro (see legend to Figure 4) at day 56.
B. IFNγ and IL-10 responses of CD4+ T cells from spleens of Salmonella-infected
IFNγB−/− chimeras, re-stimulated in vitro at day 56 (see legend to Figure 4).
Statistical analysis of A and B above was by 2-way ANOVA (*P<0.05, **P<0.01,
***P<0.001 and NS = not significant). Error bars indicate SEM. Data shown in A were
representative of 8 independent experiments and in B of 6 independent experiments. In all
panels, open symbols represent cytokineB−/− chimeric mice and black symbols wild-type
control chimeras. All the cytokine chimeras cleared bacteria normally.
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